You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study Conducted Among Patients With CML

Completed
  • Chronic Myeloid Leukemia
  • Tyrosine Kinase Inhibitors (TKIs)
  • East Hanover, New Jersey
    Novartis Investigative Site
Jul 25, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Beirut, Lebanon
      American University of Beirut Medical Center
    Feb 14, 2022

    Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

    Recruiting
    • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Augusta, Georgia
    • +1 more
    Jul 14, 2022

    Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions Trial in Ann Arbor (Patient Reported Outcome

    Terminated
    • Chronic Myeloid Leukemia
    • +2 more
    • Patient Reported Outcome Measure (PROM)
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Nov 21, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +4 more
    • Eltrombopag Olamine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2022

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +13 more
    • CMVpp65-A*0201 peptide vaccine
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +12 more
    • Tucson, Arizona
      The University of Arizona Cancer Center
    Dec 13, 2022

    Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

    Recruiting
    • Recurrent Childhood Acute Myeloid Leukemia
    • +17 more
      • Miami, Florida
        Nicklaus Children's Hospital
      May 13, 2023

      Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

      Recruiting
      • Olverembatinib
      • +2 more
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Jul 26, 2022

      Chronic Leukemia Trial in France (Additional biological samples)

      Active, not recruiting
      • Chronic Leukemia
      • Additional biological samples
      • Besançon, France
      • +3 more
      May 31, 2022

      Chronic Myeloid Leukemia (CML) Trial in France

      Recruiting
      • Chronic Myeloid Leukemia (CML)
        • Annecy, France
        • +11 more
        Jul 18, 2023

        sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

        Completed
        • Chronic Myeloid Leukemia
        • ELISA kit
        • Tanta, Egypt
          Tanta University
        May 18, 2022

        Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

        Completed
        • Chronic Myeloid Leukemia (CML)
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 31, 2022

        Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

        Completed
        Has Results
        • Myeloproliferative Disorders
        • +4 more
        • T-cell replete PBPC allograft
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Oct 12, 2022

        Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

        Withdrawn
        • Hematologic Diseases
        • +5 more
        • CliniMACS
        • +7 more
        • Miami, Florida
          Miami Cancer Institute at Baptist Health, Inc.
        Sep 26, 2022

        Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

        Recruiting
        • Chronic Myeloid Leukemia in Chronic Phase
        • Shenzhen, Guangdong, China
          Shenzhen Second People's Hospital
        Jul 26, 2022

        Chronic Myelogenous Leukemia Patients Treated With Imatinib

        Recruiting
        • Chronic Myelogenous Leukemia
        • Chart Review
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Feb 8, 2022

        Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

        Suspended
        • Juvenile Myelomonocytic Leukemia
        • +27 more
        • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Jan 11, 2023

        Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

        Recruiting
        • Acute Myeloid Leukemia
        • +6 more
        • Hyperbaric oxygen
        • Rochester, New York
          Wilmot Cancer Institute, University of Rochester
        May 16, 2022

        Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

        Recruiting
        • Myeloid Malignancies
        • +3 more
        • Houston, Texas
          M D Anderson Caner Center
        Nov 17, 2022

        Needs of 3L+ CP-CML and With T315I-mutated CML Patients

        Completed
        • Chronic Myeloid Leukemia
        • 3L Therapy
        • T315I
        • Lyon, France
          Novartis Investigative Site
        Nov 9, 2022

        Venetoclax Tablets Crushed and Dissolved Into a Solution

        Not yet recruiting
        • Hematologic Malignancy
        • +18 more
        • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
        • Cincinnati, Ohio
          Cincinnati Children's Hospital Medical Center
        Nov 8, 2023